North Carolina Booked Nearly $4 Billion In Life Sciences Investments In 2025

By Barry Teater, NC Biotech

North Carolina’s life sciences sector surged in 2025, drawing nearly $3.8 billion in new and expanded investments from global leaders in biomanufacturing, pharma, and medical technologies. Communities across the state—from Research Triangle Park and Holly Springs to Charlotte and the Piedmont Triad—saw new facilities, modernization projects, and major workforce development initiatives take shape. The year brought significant activity from companies scaling manufacturing capacity, building specialized training centers, and establishing U.S. headquarters to support continued innovation in biologics, gene therapy, advanced materials, and medical devices. These investments contributed more than 1,380 announced jobs and reinforced the state’s reputation for talent, infrastructure, and a collaborative ecosystem. With national rankings recognizing North Carolina as a top state for business and workforce development, and early 2026 already delivering billion‑dollar expansions, the momentum shows no sign of slowing.

Explore the full article for detailed project highlights and what’s driving this sustained growth.